Spondyloarthritis & psoriatic arthritis
What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK?
Authors' conclusion
Delayed axial SpA diagnosis carries high costs for society due to productivity losses.
Study context
- Population
- Simulated, literature-defined mixed cohort (64% male) assumed to have axial SpA, age at symptom onset 26 years, UKsimulated cohort
- Participants
- 1,000 participants
- Outcome
- Annual cost of delayed axial SpA diagnosis in the UK
Methodological detailsMarkov model, National Health Service (NHS) and societal perspectives, base case and probabilistic sensitivity analyses
- Markov model
- NHS and societal perspectives
- Base case and probabilistic sensitivity analyses
Main finding
As reported in the abstract
Costs of delayed axial SpA diagnosis (mean time to diagnosis 8.5 years)
- Cumulative cost of delayed diagnosis per person (95% CI 108 770-306 789)
- £193 512
- Share of costs from productivity losses
- 65.1%
- Share of costs from out-of-pocket expenses
- 31.3%
- Total annual UK cost, prevalence 0.3% (ASAS criteria)
- £3.1 billion
- Total annual UK cost, prevalence 1.2% (European Spondyloarthropathy Study Group criteria)
- £12.5 billion
Original publication
What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK? Rheumatology (Oxford). Published 25 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →